Alerts will be sent to your verified email
Verify EmailHILIKS
|
Hiliks Technologies
|
Olatech Solutions
|
iSERA Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.61 % | 24.42 % | 0.47 % |
|
5yr average Equity Multiplier
|
1.84 | 1.25 | 26.8 |
|
5yr Average Asset Turnover Ratio
|
0.44 | 1.76 | 1.36 |
|
5yr Avg Net Profit Margin
|
3.25 % | 14.41 % | -10.35 % |
|
Price to Book
|
2.61 | 0.0 | 134.58 |
|
P/E
|
364.51 | 15.69 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
536.23 Days | 116.53 Days | 222.74 Days |
|
Inventory Days
|
0.0 | 10.2 Days | 0.0 |
|
Days Receivable
|
438.68 Days | 89.2 Days | 222.74 Days |
|
Days Payable
|
-1314.6 Days | 53.67 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
8.5 | 84.5 | -13.96 |
|
5yr Avg ROCE
|
2.79 % | 32.87 % | 2.86 % |
|
5yr Avg Operating Profit Margin
|
8.53 % | 20.75 % | 2.66 % |
|
5 yr average Debt to Equity
|
0.01 | 0.05 | 14.12 |
|
5yr CAGR Net Profit
|
16.98 % | 104.0 % | n/a |
|
5yr Average Return on Assets
|
1.03 % | 19.34 % | -18.53 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
4.65 % | 62.72 % | 58.63 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-5.19 % | -1.76 % | -41.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Hiliks Technologies
|
Olatech Solutions
|
iSERA Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|